Know Cancer

or
forgot password

Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial


N/A
18 Years
N/A
Open (Enrolling)
Both
Childhood Cancers

Thank you

Trial Information

Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial


Inclusion Criteria:



- biological or foster parent of children under 18 years of age who are scheduled for
HSCT within the next month

- participant is the primary caregiver

- participant must have phone service

- caregiver speaks, reads, and writes English or Spanish (Spanish is for Childrens
Hospital Los Angeles and Columbia University only)

Exclusion Criteria:

- pediatric patient has a diagnosis of medulloblastoma or other cancer of the brain

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

Beck Depression Inventory

Outcome Time Frame:

Baseline, 1 month post-baseline, 6 mos post-baseline, 12 mos post-baseline

Safety Issue:

No

Principal Investigator

Sharon L Manne, Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Medicine and Dentistry New Jersey

Authority:

United States: Institutional Review Board

Study ID:

IRB#07-848; 15032-01

NCT ID:

NCT00939380

Start Date:

August 2008

Completion Date:

August 2013

Related Keywords:

  • Childhood Cancers
  • hematopoietic stem cell transplant
  • bone marrow transplant
  • children
  • parents
  • counseling
  • depression

Name

Location

Memorial Sloan-Kettering Cancer CenterNew York, New York  10021
Childrens Hospital Los AngelesLos Angeles, California  90027
Columbia UniversityNew York, New York  10032-3784
Emory University/Childrens Healthcare of AtlantaAtlanta, Georgia  30322
Umdnj CinjNew Brunswick, New Jersey  080903